SCHEMBL19929702

SCHEMBL19929702

C#CCOCC#CC(O)C#CCc1ccccc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 3/20 0.34
CA2 P00918 1/20 0.34
CA7 P43166 1/20 0.34
CA9 Q16790 1/20 0.34
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 2/20 0.32
TAAR1 Q96RJ0 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
MMP2 P08253 2/20 0.32
MMP12 P39900 2/20 0.32
FFAR1 O14842 1/20 0.31
FFAR4 Q5NUL3 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
TSHR P16473 1/20 0.31
MAPT P10636 1/20 0.31
KDM1A O60341 1/20 0.30
MAOA P21397 1/20 0.30
MAOB P27338 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19929694 0.85 KDM4E (0.39) NPC1MMP2MMP12CYP1A2CYP3A4
SCHEMBL19929701 0.81 KDM4E (0.36) NPC1CYP1A2CYP3A4KDM1AMAOA
SCHEMBL11363439 0.79 TSHR (0.38) FFAR1FFAR4CYP1A2CYP3A4CYP2D6
SCHEMBL19929711 0.74 HTT (0.42) NPC1ALDH1A1SMN1; SMN2FFAR1MAPT
SCHEMBL19929696 0.73 MEN1 (0.32) ALDH1A1TSHR
SCHEMBL6688790 0.72 TSHR (0.44) ALDH1A1SMN1; SMN2MMP2MMP12FFAR1
SCHEMBL19934149 0.72 MEN1 (0.30) ALDH1A1
SCHEMBL13259162 0.70 KDM4E (0.51) CA1CA2CA7CA9ALDH1A1
SCHEMBL19929741 0.68 MEN1 (0.31) ALDH1A1
SCHEMBL12341348 0.68 TRPA1 (0.41) TAAR1FFAR1FFAR4CYP2D6MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10287225-B2 Chain multiyne compound, preparation method and application thereof XIAMEN UNIVERSITY (CN) 2019-05-14 US disclosed
US-20180065908-A1 CHAIN MULTIYNE COMPOUND, PREPARATION METHOD AND APPLICATION THEREOF XIAMEN UNIVERSITY (CN) 2018-03-08 US disclosed
US-20180065908-A1 CHAIN MULTIYNE COMPOUND, PREPARATION METHOD AND APPLICATION THEREOF XIAMEN UNIVERSITY (CN) 2018-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180065908-A1 CHAIN MULTIYNE COMPOUND, PREPARATION METHOD AND APPLICATION THEREOF SQLE, COASY, MCCC2 CA1 3244/4885CA2 3640/4885CA7 1380/4885
US-10287225-B2 Chain multiyne compound, preparation method and application thereof SQLE, COASY, MCCC2 CA1 3244/4885CA2 3640/4885CA7 1380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.